PROJECT OVERVIEW

PROJECT DETAILS
  • Category About Us

Aquila Bioscience was founded in 2012 at the National University of Ireland, Galway, by Lokesh Joshi, Stokes Professor of Glycoscience. Through utilising an innovative and revolutionary decontamination technology, Aquila Bioscience offers products that protect individuals against harmful pathogens and biotoxins.

  • 2012

    Founded

    Founded by Lokesh Joshi in the National University of Ireland, Galway (NUIG)

  • 2013

    European Union project on bacterial detection in water
  • 2015

    European Defence Agency for decontaminating bacteria and bacterial toxins
  • 2016-2020 (ongoing)

    Partnership in PATHSENSE ITN focused on foodborne pathogens
  • 2017

    European Union SME-Phase 1 award to develop Glyco-DeCon technology
  • May 2019
  • 2020

    European Union SME-Phase 2 Application in process to develop ABD technology
  • March 2020

    CEO & Aquila team appointed
  • March 2020

    1st ABD produced by Aquila
  • April 2020

    1st ABD delivered to customer
  • June 2020

    Aquila Bioscience is selected for EIC Accelerator Funding
  • March 2021

    Aquila Bioscience launches ProShield Mask Spray
  • Dec 2021

    Patent Nationalisation